The impact of the GMO regulations on a UK pharmaceutical company
β Scribed by Paul Burke
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1995
- Tongue
- English
- Weight
- 352 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0268-2575
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Introduction 1. Council Regulation (EC) No.1346/2000 of 29 May 2000 on Insolvency Proceed- ings (''the Regulation'') 1 will actually or potentially aΒ‘ect every type of insolvency proceeding in the UK. This paper will, however, generally conΒ’ne itself to that part of the UK known as England andWales
International trade and global environmental protection have become the objects of intense debate. One aspect of this debate concerns the effects of environmental regulations on international competitiveness. In this article, the impact of environmental regulations on grain trade patterns is examine
Over the past two decades, competition in the pharmaceutical industry has been characterized by three factors: 1. Competitive advantage driven by blockbuster drugs 2. Vertical integration from discovery through sales 3. Peripheral role as suppliers in the health care system In this environment, suc
## Abstract Little is known about the possible impact of an influenza pandemic on a nation's economy. We applied the UK macroeconomic model βCOMPACTβ to epidemiological data on previous UK influenza pandemics, and extrapolated a sensitivity analysis to cover more extreme disease scenarios. Analysis
## Abstract Nonβcompliance with drug therapies not only limits their effectiveness, but in some instances, is associated with grave clinical sequelae and substantial economic burden. It is important, therefore, to consider nonβcompliance in economic evaluations. A review of pharmacoeconomic evaluat